The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.

Muñoz-Novas, Carolina

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index. [electronic resource] - BioMed research international 2018 - 9506979 p. digital

Publication Type: Journal Article

2314-6141

10.1155/2018/9506979 doi


Aged
Biomarkers, Tumor--genetics
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis
Male
Middle Aged
Predictive Value of Tests
Prognosis
Retrospective Studies